Td Private Client Wealth LLC Ionis Pharmaceuticals Inc Transaction History

Td Private Client Wealth LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Aug 16, 2024	SELL	$25.61 - $35.1 $281 - $386	-11 Closed	0 $0
Q3 2021 Aug 16, 2024	BUY	$33.54 - $40.55 $368 - $446	11 New	11 $369,000
Q2 2021 Aug 16, 2024	BUY	$34.54 - $47.25 $3,419 - $4,677	99 Added 330.0%	129 $5.15 Million
Q1 2021 Aug 16, 2024	SELL	$42.51 - $63.78 $3,103 - $4,655	-73 Reduced 70.87%	30 $1.35 Million
Q4 2020 Aug 16, 2024	BUY	$45.3 - $60.27 $860 - $1,145	19 Added 22.62%	103 $5.82 Million
Q4 2019 Aug 16, 2024	BUY	$53.85 - $65.27 $4,523 - $5,482	84 New	84 $5.07 Million

394

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.01B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.